0001140361-17-032479.txt : 20170816 0001140361-17-032479.hdr.sgml : 20170816 20170816172238 ACCESSION NUMBER: 0001140361-17-032479 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170814 FILED AS OF DATE: 20170816 DATE AS OF CHANGE: 20170816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Van Naarden Jacob CENTRAL INDEX KEY: 0001661254 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36562 FILM NUMBER: 171037059 MAIL ADDRESS: STREET 1: C/O LOXO ONCOLOGY, INC. STREET 2: ONE LANDMARK SQUARE, SUITE 1122 CITY: STAMFORD STATE: CT ZIP: 06901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Loxo Oncology, Inc. CENTRAL INDEX KEY: 0001581720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462996673 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 281 TRESSER BOULEVARD, 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 203-653-3880 MAIL ADDRESS: STREET 1: 281 TRESSER BOULEVARD, 9TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06901 4 1 doc1.xml FORM 4 X0306 4 2017-08-14 0 0001581720 Loxo Oncology, Inc. LOXO 0001661254 Van Naarden Jacob C/O LOXO ONCOLOGY, INC. 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 0 1 0 0 Chief Business Officer Common Stock 2017-08-14 4 M 0 1541 3.648 A 1541 D Common Stock 2017-08-14 4 S 0 1000 73.5450 D 541 D Common Stock 2017-08-14 4 S 0 541 74.074 D 0 D Common Stock 2017-08-15 4 M 0 1541 3.648 A 1541 D Common Stock 2017-08-15 4 S 0 1541 73.4158 D 0 D Employee Stock Option (right to buy) 3.648 2017-08-14 4 M 0 1541 0 D 2024-06-18 Common Stock 1541 127412 D Employee Stock Option (right to buy) 3.648 2017-08-15 4 M 0 1541 0 D 2024-06-18 Common Stock 1541 125871 D The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Represents the aggregate of sales effected on the same day at different prices. Represents the weighted average sales price per share. The shares sold at prices ranging from $72.94 to $73.89 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $73.97 to $74.31 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $73.04 to $73.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. The stock option vested and became exercisable as to 25% of the shares subject to the option on May 12, 2015, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. /s/ Jennifer Burstein, by power of attorney 2017-08-16